EyePoint Pharmaceuticals (EYPT) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2024, EyePoint Pharmaceuticals (EYPT) reported revenue of $11.59 million, down 17.4% over the same period last year. EPS came in at -$0.64, compared to -$0.33 in the year-ago quarter.The reported revenue represents a surprise of -21.04% over the Zacks Consensus Estimate of $14.68 million. With the consensus EPS estimate being -$0.41, the EPS surprise was -56.10%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expecta ...